Related Experiment Video
Updated: Apr 30, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Cardiovascular complications of diabetic kidney disease
Ragnar Pálsson1, Uptal D Patel1
1Department of Medicine, Durham Veterans Affairs Medical Center and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
Insights
Diabetic nephropathy significantly increases cardiovascular risks and mortality in patients with chronic kidney disease (CKD). Addressing this requires greater awareness and timely interventions to improve outcomes for this vulnerable population.
Area of Science:
- Nephrology
- Cardiology
- Diabetology
Background:
- Diabetic nephropathy is a leading cause of chronic kidney disease (CKD).
- Patients with diabetic kidney disease exhibit high rates of cardiovascular morbidity and mortality.
- The link between diabetic kidney disease and cardiovascular disease is not fully understood, with traditional risk factors insufficient to explain the elevated risk.
Purpose of the Study:
- To highlight the significant cardiovascular risks associated with diabetic nephropathy.
- To underscore the need for improved risk factor modification and timely interventions in CKD patients.
- To identify current treatment mainstays and acknowledge evidence gaps for diabetic kidney disease.
Main Methods:
- Review of existing literature on diabetic nephropathy and cardiovascular disease.
- Analysis of mortality and morbidity data in diabetic populations with and without kidney disease.
- Examination of current treatment guidelines and clinical trial limitations.
Main Results:
- Diabetic kidney disease is strongly associated with increased cardiovascular disease burden and mortality.
- Traditional cardiovascular risk factors do not fully explain the heightened risk in this population.
- Patients with CKD often receive suboptimal risk factor management and are underrepresented in cardiovascular trials.
Conclusions:
- Increased awareness and prompt interventions are crucial for improving outcomes in patients with diabetic nephropathy.
- Further research is needed to fill evidence gaps and develop targeted treatments for cardiovascular complications in CKD.
- Current management focuses on renin-angiotensin-aldosterone system blockade, hypertension, hyperglycemia, and dyslipidemia control.
Abstract:
Diabetic nephropathy is the most common cause of CKD and represents a large and ominous public health problem. Patients with diabetic kidney disease have exceptionally high rates of cardiovascular morbidity and mortality. In fact, the excess mortality among patients with diabetes appears to be largely limited to the subgroup with kidney disease and explained by their high burden of cardiovascular disease. The mechanisms underlying the strong association between diabetic kidney disease and various forms of cardiovascular disease are poorly understood. Traditional risk factors for cardiovascular disease, although prevalent among those with diabetes, do not fully account for the heightened risk observed. Despite their susceptibility to cardiovascular disease, patients with CKD are less likely to receive appropriate risk factor modification than the general population. Moreover, because patients with CKD have commonly been excluded from major cardiovascular trials, the evidence for potential treatments remains limited. The mainstays of treatment for diabetic kidney disease currently include blockade of the renin-angiotensin-aldosterone system and control of hypertension, hyperglycemia, and dyslipidemia. Increased awareness of the vulnerability of this patient population and more timely interventions are likely to improve outcomes while large evidence gaps are filled with newer studies.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Retinopathy
Chronic Kidney Disease IV: Nursing Management
Diabetes: Symptoms, Diagnosis, and Complications

